Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Stanley

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Coronary Artery Disease|December 13, 2005
Diabetes and ischaemic heart disease: essential role for metabolic therapiesWilliam C Stanley
Coronary Artery Disease|December 13, 2005
Rationale for a metabolic approach in diabetic coronary patientsWilliam C Stanley
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2004
Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapiesWilliam C Stanley
Expert Review of Cardiovascular Therapy|September 27, 2005
Ranolazine: new approach for the treatment of stable angina pectorisWilliam C Stanley
Heart Failure Reviews|May 4, 2002
Introduction to special issue on myocardial energy metabolism in heart failureWilliam C Stanley
Expert Opinion on Investigational Drugs|May 9, 2002
Partial fatty acid oxidation inhibitors for stable anginaWilliam C Stanley
Heart Failure Reviews|September 19, 2013
Introduction to special issue on cardiac metabolism in hypertrophy and failureWilliam C Stanley
Journal of Molecular and Cellular Cardiology|September 28, 2010
Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotectionHeinrich Taegtmeyer, William C Stanley
Fundamental & Clinical Pharmacology|April 2, 2003
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidineWilliam C Stanley, Mario Marzilli
Cardiovascular Drugs and Therapy|December 1, 2006
Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart diseaseGary D Lopaschuk, William C Stanley
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Coronary Artery Disease|December 13, 2005
Diabetes and ischaemic heart disease: essential role for metabolic therapiesWilliam C Stanley
Coronary Artery Disease|December 13, 2005
Rationale for a metabolic approach in diabetic coronary patientsWilliam C Stanley
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2004
Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapiesWilliam C Stanley
Expert Review of Cardiovascular Therapy|September 27, 2005
Ranolazine: new approach for the treatment of stable angina pectorisWilliam C Stanley
Heart Failure Reviews|May 4, 2002
Introduction to special issue on myocardial energy metabolism in heart failureWilliam C Stanley
Expert Opinion on Investigational Drugs|May 9, 2002
Partial fatty acid oxidation inhibitors for stable anginaWilliam C Stanley
Heart Failure Reviews|September 19, 2013
Introduction to special issue on cardiac metabolism in hypertrophy and failureWilliam C Stanley
Journal of Molecular and Cellular Cardiology|September 28, 2010
Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotectionHeinrich Taegtmeyer, William C Stanley
Fundamental & Clinical Pharmacology|April 2, 2003
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidineWilliam C Stanley, Mario Marzilli
Cardiovascular Drugs and Therapy|December 1, 2006
Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart diseaseGary D Lopaschuk, William C Stanley
Pageof 14